EC ever use among women of reproductive age: 0.2% (DHS 2006)
EC knowledge among women of reproductive age: 19.0% (DHS 2012-2013)
Contraceptive Use: 17.5 (DHS 2006, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- Escinor 1.5 - Available directly from pharmacist without prescription (i.e. BTC)
- NorLevo 1.5mg* - Available directly from pharmacist without prescription (i.e. BTC)
- Optinor - Available only from family planning clinics (applies to Optinor in most countries)
- Pregnon - Available directly from pharmacist without prescription (i.e. BTC)
- Vikela* - Available directly from pharmacist without prescription (i.e. BTC)
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: Essential Medicines List
Other relevant information: EC distributed via IPPF outlets (10,000 - 20,000 in 2012).
In 2013, EC was not procured by the government (JSI/Deliver data).